+57.9%
QQQM vs GSK
+40.7%
+17.3%
-35.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.4% | -0.1% | -5.3% | -5.4% |
| 7D | -10.3% | -5.3% | -4.9% | -9.7% |
| 30D | -15.9% | -3.7% | -12.2% | -15.5% |
| 3M | -14.1% | -7.3% | -6.8% | -13.4% |
| 6M | -14.3% | -4.2% | -10.0% | -14.1% |
| YTD | -0.3% | +0.9% | -1.2% | -1.1% |
| 1Y | +4.7% | +7.3% | -2.6% | +2.8% |
| 3Y | +59.1% | +52.7% | +6.4% | +43.5% |
| All | +57.9% | +40.7% | +17.3% | +32.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling